Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
# Squarespace Robots Txt User-agent: AdsBot-Google Disallow: /config Disallow: /search Disallow: /account$ Disallow: /account/ Disallow: /commerce/digital-download/ Disallow: /api/ Allow: /api/ui-extensions/ Disallow: /static/ Disallow:/*?author=* Disallow:/*&author=* Disallow:/*?tag=* Disallow:/*&tag=* Disallow:/*?month=* Disallow:/*&month=* Disallow:/*?view=* Disallow:/*&view=* Disallow:/*?format=json Disallow:/*&format=json Disallow:/*?format=page-context Disallow:/*&format=page-context Disallow:/*?format=main-content Disallow:/*&format=main-content Disallow:/*?format=json-pretty Disallow:/*&format=json-pretty Disallow:/*?format=ical Disallow:/*&format=ical Disallow:/*?reversePaginate=* Disallow:/*&reversePaginate=* User-agent: AdsBot-Google-Mobile Disallow: /config Disallow: /search Disallow: /account$ Disallow: /account/ Disallow: /commerce/digital-download/ Disallow: /api/ Allow: /api/ui-extensions/ Disallow: /static/ Disallow:/*?author=* Disallow:/*&author=* Disallow:/*?tag=* |
Title | New Amsterdam |
Description | Powered by cutting-edge 0 Skip to Content Home About Us Scientific Approach Our Science Biology Overview Therapeutic Areas Program Obicetrapib (TA-8995) Expanded Access Investors |
Keywords | N/A |
WebSite | newamsterdampharma.com |
Host IP | 198.49.23.144 |
Location | United States |
Site | Rank |
US$7,103,664
Last updated: 2023-05-08 06:23:32
newamsterdampharma.com has Semrush global rank of 1,489,978. newamsterdampharma.com has an estimated worth of US$ 7,103,664, based on its estimated Ads revenue. newamsterdampharma.com receives approximately 819,654 unique visitors each day. Its web server is located in United States, with IP address 198.49.23.144. According to SiteAdvisor, newamsterdampharma.com is safe to visit. |
Purchase/Sale Value | US$7,103,664 |
Daily Ads Revenue | US$6,558 |
Monthly Ads Revenue | US$196,717 |
Yearly Ads Revenue | US$2,360,603 |
Daily Unique Visitors | 54,644 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
newamsterdampharma.com. | A | 3599 | IP: 198.49.23.144 |
newamsterdampharma.com. | A | 3599 | IP: 198.185.159.145 |
newamsterdampharma.com. | A | 3599 | IP: 198.49.23.145 |
newamsterdampharma.com. | A | 3599 | IP: 198.185.159.144 |
newamsterdampharma.com. | NS | 86400 | NS Record: ns0.nl. |
newamsterdampharma.com. | NS | 86400 | NS Record: ns11.net. |
newamsterdampharma.com. | NS | 86400 | NS Record: ns5.be. |
newamsterdampharma.com. | MX | 3600 | MX Record: 0 NewAmsterdamPharma-com.mail.protection.outlook.com. |
newamsterdampharma.com. | TXT | 3600 | TXT Record: MS=ms57595901 |
newamsterdampharma.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
0 Skip to Content Home About Us Scientific Approach Our Science Biology Overview Therapeutic Areas Program Obicetrapib (TA-8995) Expanded Access Investors & News Contact & Careers Open Menu Close Menu Home About Us Scientific Approach Our Science Biology Overview Therapeutic Areas Program Obicetrapib (TA-8995) Expanded Access Investors & News Contact & Careers Open Menu Close Menu Home About Us Folder: Scientific Approach Back Our Science Biology Overview Therapeutic Areas Folder: Program Back Obicetrapib (TA-8995) Expanded Access Investors & News Contact & Careers Powered by cutting-edge genetics We are developing transformative, clinically validated oral therapies for patients with metabolic diseases. Learn more Our Mission At NewAmsterdam Pharma, we are passionate about providing transformational therapies for patients suffering from an array of conditions where aberrant cholesterol metabolism still underlies significant morbidity and mortality despite treatment with existing |
HTTP/1.1 301 Moved Permanently Age: 585424 Date: Fri, 22 Oct 2021 18:26:27 GMT Location: https://www.newamsterdampharma.com/ Server: Squarespace Set-Cookie: crumb=BSsCsBgHdiDCMjlmNWJiZGI0ZGE4MTNlODMwOTk5ZjU0OTU3YTk4;Path=/ X-Contextid: uJYh1qJT/PmczwdWU HTTP/2 200 accept-ranges: bytes age: 585423 content-type: text/html;charset=utf-8 date: Fri, 22 Oct 2021 18:26:29 GMT etag: W/"08732e816a884244436d4543b024d44e--gzip" expires: Thu, 01 Jan 1970 00:00:00 GMT server: Squarespace set-cookie: crumb=BSsxxb7Ccg3/NjBjYjdjMjg1MTEyMDRmNjNlODYxOGQyYmQxZTY2;Path=/ strict-transport-security: max-age=0 vary: Accept-Encoding x-content-type-options: nosniff x-contextid: 8XHM6oVx/n0TohxWZ |
Domain Name: NEWAMSTERDAMPHARMA.COM Registry Domain ID: 2465432868_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.rrpproxy.net Registrar URL: http://www.key-systems.net Updated Date: 2021-07-22T13:07:01Z Creation Date: 2019-12-10T09:18:33Z Registry Expiry Date: 2021-12-10T09:18:33Z Registrar: Key-Systems GmbH Registrar IANA ID: 269 Registrar Abuse Contact Email: abuse@key-systems.net Registrar Abuse Contact Phone: +49.68949396850 Domain Status: ok https://icann.org/epp#ok Name Server: NS0.NL Name Server: NS11.NET Name Server: NS5.BE DNSSEC: signedDelegation DNSSEC DS Data: 56543 13 2 537A698B05C5B44E76D078F5455F4AFCF64E557ABE479EF12125BC9E257BF0F9 >>> Last update of whois database: 2021-09-17T02:11:28Z <<< |